Table 1.
Patient and treatment characteristics assumptions used to inform critical care drug requirements
| Therapeutic group | Typical length of COVID-related stay=12.4 days | |
| ICU population uptake | Average treatment length | |
| CRRT (Continuous Renal Replacement Therapy) | 20% | 7 days |
| Vasopressors | 50% | 5 days |
| Vasopressor adjunct (vasopressin) | 10% | 5 days |
| Sedation | 100% | 9 days |
| Neuromuscular blockade (maintenance) | 85% | 8 days |
| Neuromuscular blockade (intubations) | 85% | 1 day |
| Care bundle compliance | 100% | 12.4 days |
| Enteral feed | 100% | 12.4 days |
| Bronchodilators | 100% | 7 days |
| IV fluids | 100% | 7 days |
ICU, intensive care unit.